Brief: Ipsen FY Adjusted EPS EUR 10.27 Vs. IBES Estimate EUR 9.5
13/02/2025 05:57
Feb 13 (Reuters) - Ipsen FY EPS EUR 4.15. * FY revenue EUR 3,400.6 million vs. IBES estimate EUR 3,487 million * FY EBIT margin 14.6% * FY adjusted EBIT EUR 1,109.4 million vs. IBES estimate EUR 1,016 million * FY EBIT EUR 496.7 million * FY adjusted EBIT margin 32.6%
Recent news on Ipsen SA
See all newsFulcrum falls after discontinuing sickle cell drug program
Fulcrum falls after discontinuing sickle cell drug program
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
Fulcrum Therapeutics falls after scrapping sickle cell drug development
Brief: Ipsen's IQIRVO Shows Meaningful Fatigue Improvements In Moderate-To-Severe PBC Patients